The store will not work correctly when cookies are disabled.
Myristoyl Sarcosine
ID: ALA4462773
Cas Number: 52558-73-3
PubChem CID: 104234
Max Phase: Preclinical
Molecular Formula: C17H33NO3
Molecular Weight: 299.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCCCCC(=O)N(C)CC(=O)O
Standard InChI: InChI=1S/C17H33NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-16(19)18(2)15-17(20)21/h3-15H2,1-2H3,(H,20,21)
Standard InChI Key: NGOZDSMNMIRDFP-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 20 0 0 0 0 0 0 0 0999 V2000
23.7192 -26.4555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4270 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1391 -26.4557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8472 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8472 -25.2286 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5553 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2675 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9756 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6836 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3917 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1039 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8120 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5200 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2281 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9362 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6484 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3564 -26.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0645 -26.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1391 -27.2752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7192 -27.2750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0111 -26.0479 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
4 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
3 19 1 0
1 20 2 0
1 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.45 | Molecular Weight (Monoisotopic): 299.2460 | AlogP: 4.23 | #Rotatable Bonds: 14 |
Polar Surface Area: 57.61 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.12 | CX Basic pKa: ┄ | CX LogP: 4.49 | CX LogD: 1.40 |
Aromatic Rings: ┄ | Heavy Atoms: 21 | QED Weighted: 0.49 | Np Likeness Score: -0.24 |
References
1. (2013) Method for treating skin with retinoids and retinoid boosters, |